: Understanding drug behavior at the molecular level allows researchers to interpret dose-response data. This includes characterizing: : How strongly a drug binds to its target. Intrinsic Efficacy
When a drug enters Phase I trials, the discipline shifts from discovery pharmacology to clinical pharmacology . The goal is to translate animal PK/PD to humans.
The preclinical phase involves testing the lead compound in vitro (in a laboratory dish) and in vivo (in animals) to assess its:
PD tells you the dose needed; PK tells you if you can deliver it.
Answering those questions with rigor and creativity is not just a job for pharmacologists. It is the solemn responsibility of everyone involved in turning molecules into medicines.
: Understanding drug behavior at the molecular level allows researchers to interpret dose-response data. This includes characterizing: : How strongly a drug binds to its target. Intrinsic Efficacy
When a drug enters Phase I trials, the discipline shifts from discovery pharmacology to clinical pharmacology . The goal is to translate animal PK/PD to humans. pharmacology in drug discovery and development
The preclinical phase involves testing the lead compound in vitro (in a laboratory dish) and in vivo (in animals) to assess its: : Understanding drug behavior at the molecular level
PD tells you the dose needed; PK tells you if you can deliver it. pharmacology in drug discovery and development
Answering those questions with rigor and creativity is not just a job for pharmacologists. It is the solemn responsibility of everyone involved in turning molecules into medicines.